Carl Goldfischer

Insider profile

Currently holds positions in Poniard Pharmaceuticals Inc, Cymabay Therapeutics Inc and Epizyme Inc

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -25% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Poniard Pharmaceuticals Inc March 1, 2000 -
Independent Director Cymabay Therapeutics Inc Aug. 1, 2003 -
Independent Director Epizyme Inc Sept. 1, 2009 -
Independent Director ReShape Lifesciences Inc July 1, 2004 - Sept. 30, 2017
Director PTC Therapeutics Inc March 1, 2002 - Jan. 1, 2013
Carl Goldfischer's trades of Epizyme Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Epizyme Inc (EPZM)
Transaction date
Purchase
Price
236.49
Quantity 80,238 +46.5%
Value US$1,788,739
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-13 2020-11-11
US Epizyme Inc (EPZM)
B Purchase
80,238 +46.5%
236.49
US$1,788,739 		80,238 +46.5% 236.49 US$1,788,739
2019-02-08 2019-02-07
S Sale
21,201 -35.0%
306.39
US$3,293,537 		21,201 -35.0% 306.39 US$3,293,537